secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2024-07-02T23:59:59+00:00
Accession:  0001493152-24-025929
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $33,750 convertible note with 35% discount for working capital
--------------------------------------------------------------------------------

- Issued convertible promissory note to 104 LLC for gross proceeds of $30,375 after $2,500 legal fee deduction.
- Note matures June 20, 2025, bears 10% interest (16% on default), convertible at 65% of lowest closing price over prior 10 days.
- Company can prepay at premiums 110-125% of face within first 180 days; no prepayment right after.
- Net proceeds used for general working capital; issued under Section 4(a)(2)/Rule 506(b) exemption.
- Conversion shares subject to 4.99% beneficial ownership limitation and 500% reserve requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224025929/0001493152-24-025929-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224025929/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-025929

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer